November 2015

Study identifies eye-drop-soluble compound that could treat cataracts

Tue Nov 17, 2015

Cataracts are the leading cause of blindness worldwide, the leading cause of vision loss in the United States, and cases are increasing with an aging population. Currently the condition can be treated with surgery—an expensive intervention that leaves most patients blinded in developing countries untreated.

Shoichet study sheds light on “dark” cell receptors, potential drug targets

Mon Nov 9, 2015

More than a quarter of all drugs work by targeting one of a large family of proteins called G-protein-coupled receptors (GPCRs). Hundreds of different GPCRs are embedded in cell membranes, converting stimuli from the outside world—neurotransmitters, hormones, even light—into intracellular signals that can change cell behavior.

Aashish Manglik Seminar

Tuesday, November 17, 2015 - 11:00 am to 12:30 pm

Aashish Manglik, PhD of Stanford University presents:



"Structural insights into G protein coupled receptor function"



 



Aashish is a physician-scientist in training with an interest in understanding human physiology from a biochemical perspective. He is particularly motivated to leverage recent advances in the understanding of G protein-coupled receptors to study and address various clinical diseases.



 

Update from the Dean - Fall/Winter 2015

Tue Nov 3, 2015
Guglielmo
Strategic planning; Recently received research funding: cancer, Alzheimer's, HIV, type 2 diabetes (Kroetz, Keiser, Gross, Roy); Recent faculty publications: fibrosis, biofilms, gout (DeGrado, Yang, Giacomini); Collaborations and partnerships; Patient care: SB 493, scope of practice for California pharmacists; Education: Precision Medicine Student Alliance; New PharmD curriculum development; Faculty honors: Abate, Benet, Burchard, Desai, MacDougall, Wells, Yokoyama; Alumni honors: Levin, Schweitz